PMSNF.US Proteome Sciences plc

Healthcare Biotechnology USA Stocks
0.0100 USD
Close of Nov 18, 2026
0.0100 0.0400
Market cap
USD 3.51M
P/E
-
P/B
680.56x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is PMSNF.US undervalued?

Graham number

The Graham number of Proteome Sciences plc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Proteome Sciences plc fundamental analysis

No fundamental analysis for Proteome Sciences plc yet.

Proteome Sciences plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Proteome Sciences plc

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant that pro…

Full company profile